关注
Neil Guha
Neil Guha
Professor of Hepatology , Univeristy of Nottingham
在 nottingham.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease
PJ Eddowes, M Sasso, M Allison, E Tsochatzis, QM Anstee, D Sheridan, ...
Gastroenterology 156 (6), 1717-1730, 2019
10442019
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
IN Guha, J Parkes, P Roderick, D Chattopadhyay, R Cross, S Harris, ...
Hepatology 47 (2), 455-460, 2008
9312008
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation …
PN Newsome, M Sasso, JJ Deeks, A Paredes, J Boursier, WK Chan, ...
The lancet Gastroenterology & hepatology 5 (4), 362-373, 2020
5722020
Performance of serum marker panels for liver fibrosis in chronic hepatitis C
J Parkes, IN Guha, P Roderick, W Rosenberg
Journal of hepatology 44 (3), 462-474, 2006
3082006
Prediction, prevention and management of postresection liver failure
JS Hammond, IN Guha, IJ Beckingham, DN Lobo
Journal of British Surgery 98 (9), 1188-1200, 2011
2412011
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
R Fan, G Papatheodoridis, J Sun, H Innes, H Toyoda, Q Xie, S Mo, ...
Journal of hepatology 73 (6), 1368-1378, 2020
2262020
ADAPT: an algorithm incorporating PRO‐C3 accurately identifies patients with NAFLD and advanced fibrosis
SJ Daniels, DJ Leeming, M Eslam, AM Hashem, MJ Nielsen, A Krag, ...
Hepatology 69 (3), 1075-1086, 2019
2252019
Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C
J Parkes, IN Guha, P Roderick, S Harris, R Cross, MM Manos, W Irving, ...
Journal of viral hepatitis 18 (1), 23-31, 2011
2142011
Consistent beneficial effects of killer cell immunoglobulin‐like receptor 2DL3 and group 1 human leukocyte antigen‐C following exposure to hepatitis C virus
S Knapp, U Warshow, D Hegazy, L Brackenbury, IN Guha, A Fowell, ...
Hepatology 51 (4), 1168-1175, 2010
2072010
Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review
R Harris, DJ Harman, TR Card, GP Aithal, IN Guha
The lancet Gastroenterology & hepatology 2 (4), 288-297, 2017
1952017
Screening for liver fibrosis in the general population: a call for action
P Ginès, I Graupera, F Lammert, P Angeli, L Caballeria, A Krag, IN Guha, ...
The lancet Gastroenterology & hepatology 1 (3), 256-260, 2016
1842016
Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease
IN Guha, J Parkes, PR Roderick, S Harris, WM Rosenberg
Gut 55 (11), 1650-1660, 2006
1802006
Population screening for liver fibrosis: toward early diagnosis and intervention for chronic liver diseases
P Ginès, L Castera, F Lammert, I Graupera, M Serra‐Burriel, AM Allen, ...
Hepatology 75 (1), 219-228, 2022
1672022
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
S Tanwar, PM Trembling, IN Guha, J Parkes, P Kaye, AD Burt, SD Ryder, ...
Hepatology 57 (1), 103-111, 2013
1522013
A study of T1 relaxation time as a measure of liver fibrosis and the influence of confounding histological factors
CL Hoad, N Palaniyappan, P Kaye, Y Chernova, MW James, C Costigan, ...
NMR in Biomedicine 28 (6), 706-714, 2015
1462015
Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population
I Graupera, M Thiele, M Serra-Burriel, L Caballeria, D Roulot, GLH Wong, ...
Clinical Gastroenterology and Hepatology 20 (11), 2567-2576. e6, 2022
1402022
Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia
M Serra-Burriel, I Graupera, P Torán, M Thiele, D Roulot, VWS Wong, ...
Journal of hepatology 71 (6), 1141-1151, 2019
1382019
Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging
N Palaniyappan, E Cox, C Bradley, R Scott, A Austin, R O’Neill, G Ramjas, ...
Journal of hepatology 65 (6), 1131-1139, 2016
1282016
Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography
DJ Harman, SD Ryder, MW James, M Jelpke, DS Ottey, EA Wilkes, ...
BMJ open 5 (4), e007516, 2015
1202015
Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans
J Pritchett, E Harvey, V Athwal, A Berry, C Rowe, F Oakley, A Moles, ...
Hepatology 56 (3), 1108-1116, 2012
1152012
系统目前无法执行此操作,请稍后再试。
文章 1–20